NCT01553188 : Clinical Trial Detail - Cancer Knowledgebase (CKB)

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT01553188
Title	AMG 386 and Abiraterone for Advanced Prostate Cancer
Recruitment	Completed
Gender	male
Phase	Phase II
Variant Requirements	No
Sponsors	National Cancer Institute (NCI)
Indications	prostate cancer
Therapies	Prednisone Abiraterone Trebananib
Age Groups:	adult
Covered Countries	USA

Filter rows:

Showing 1 to 2 of 2 entries

Facility	Status	City	State	Zip	Country	Details
Fox Chase Cancer Center		Philadelphia	Pennsylvania	19111	United States	Details
National Institutes of Health Clinical Center, 9000 Rockville Pike		Bethesda	Maryland	20892	United States	Details

Showing 1 to 2 of 2 entries

Filter rows:

*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field

NCT01553188Clinical Trial Detail